Cargando…
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
Persistence of latently infected cells in presence of Anti-Retroviral Therapy presents the main obstacle to HIV-1 eradication. Much effort is thus placed on identification of compounds capable of HIV-1 latency reversal in order to render infected cells susceptible to viral cytopathic effects and imm...
Autores principales: | Stoszko, Mateusz, De Crignis, Elisa, Rokx, Casper, Khalid, Mir Mubashir, Lungu, Cynthia, Palstra, Robert-Jan, Kan, Tsung Wai, Boucher, Charles, Verbon, Annelies, Dykhuizen, Emily C., Mahmoudi, Tokameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739437/ https://www.ncbi.nlm.nih.gov/pubmed/26870822 http://dx.doi.org/10.1016/j.ebiom.2015.11.047 |
Ejemplares similares
-
The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012) -
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy
por: Prins, Henrieke A. B., et al.
Publicado: (2023) -
A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency
por: Röling, Michael, et al.
Publicado: (2021) -
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency
por: Stoszko, Mateusz, et al.
Publicado: (2020) -
The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
por: Debrabander, Quinten, et al.
Publicado: (2023)